Association between vitamin D, glycemic control and microvascular complications in type 1 diabetes

Authors

  • Camila Lousada Herbster Ferraz Universidade Federal do Ceara
  • Angela Delmira Nunes Mendes Ambulatório de Diabetes tipo 1 do Serviço de Endocrinologia e Metabologia do Hospital Universitário Walter Cantídio – UFC
  • Tania Maria Bulcão Lousada Ferraz Hospital Geral de Fortaleza
  • Carlos Antonio Bruno da Silva Universidade de Fortaleza http://orcid.org/0000-0002-2968-9206

DOI:

https://doi.org/10.5020/18061230.2018.6993

Keywords:

Diabetes Mellitus, Vitamin D, Medical Records.

Abstract

Objectives: To assess the association between vitamin D levels, parameters of metabolic control and presence of microvascular complications in type 1 diabetes mellitus (T1DM) patients. Methods: Analytical and observational cross-sectional study of medical records of fifty patients carried out in 2016 in Fortaleza, Ceará. Clinical and epidemiological data were analyzed: sex, age, BMI (body mass index), skin color, glycemic control, duration of diabetes, daily insulin dose, presence of microvascular complications, and vitamin D assay by chemiluminescence. Fisher’s test, students’s t test and Mann-Whitney U test were used with p< 0.05. Results: Vitamin D deficiency was seen in 34 (68%) patients, with a mean of 25(OH) vitamin D of 23.24±4.29 ng/mL in the Vitamin D deficiency group and 38.22±7.72 ng/mL in the normal Vitamin D group. In addition, 37 patients (78%) exhibited glycated hemoglobin above 7%, which was similar in booth groups. The daily insulin dose in the vitamin D deficiency group was higher than in the normal vitamin D group, 54.81+27.4 vs 55.55+19.2, but with no significant association with vitamin D levels. Vitamin D levels were not associated with clinical and epidemiological such as: sex, age, BMI, skin color, glycemic control, duration of diabetes, daily insulin dose and presence of microvascular complications or insulin daily dose. Conclusion: Vitamin D deficiency was present in most of the T1DM patients analyzed. However, such deficiency was not associated with the clinical and epidemiological variables analyzed.

Downloads

Download data is not yet available.

Author Biographies

Camila Lousada Herbster Ferraz, Universidade Federal do Ceara

Residente de Endocrinologia e Metabologia do Hospital Universitário Walter Cantídio – UFC

Angela Delmira Nunes Mendes, Ambulatório de Diabetes tipo 1 do Serviço de Endocrinologia e Metabologia do Hospital Universitário Walter Cantídio – UFC

Medica Endocrinologista

Tania Maria Bulcão Lousada Ferraz, Hospital Geral de Fortaleza

Médica Endocrinologista, Doutora em Endocrinologia pela Escola Paulista de Medicina Fortaleza, UNIFESP São Paulo, Brasil

Carlos Antonio Bruno da Silva, Universidade de Fortaleza

Possui graduação em Medicina pela Universidade Federal do Ceará (1988), mestrado em Medicina (Clínica Médica) pela Universidade Federal do Ceará (1997) e doutorado em Ciências da Saúde pela Universidade de Brasília (2000). Atualmente é professor titular da Universidade de Fortaleza, médico do Governo do Estado do Ceará, - Parecerista do Jormal de Pediatria e dos Cadernos de Saúde Pública (FIOCRUZ) e gerente científico - Pronutrir -Suporte Nutricional e Quimioterapia Ltda. Tem experiência na área de Medicina, com ênfase em Endocrinologia, Nutrição e Educação em Saúde, atuando principalmente nos seguintes temas: nutrição, endocrinologia, diabetes mellitus e avaliação nutricional.

References

American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2017;40 (Suppl 1):S11-24

Milech A, Perez A, Golbert AA et al. Diretrizes da Sociedade Brasileira de Diabetes (2015-2016). São Paulo: A.C. Farmacêutica; 2016.

Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4-14.

Wolden-Kirk H, Overbergh L, Christesen HT, Brusgaard K, Mathieu C. Vitamin D and diabetes: its importance for beta cell and immune function. Mol Cell Endocrinol. 2011;347(1-2):106-20.

Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet, 2014;383(9911):69-82.

Egro FM. Why is type 1 diabetes increasing? J Mol Endocrinol. 2013;51(1):R1-13.

Griz LH, Bandeira F, Gabbay MA, Dib SA, Carvalho EF. Vitamin D and diabetes mellitus: an update 2013. Arq Bras Endocrinol Metabol. 2014;58(1):1-8.

Gabbay MA, Sato MN, Finazzo C, Duarte AJ, Dib AS. Effect of cholecalciferol as adjunctive therapy with insulin on protective immunologic profile and decline of residual β-cell function in new-onset type 1 diabetes mellitus. Arch Pediatr Adolesc Med. 2012;166(7):601-7.

Mishra A, Dayal D, Sachdeva N, Attri SV. Effect of 6-months' vitamin D supplementation on residual beta cell function in children with type 1 diabetes: a case control interventional study. J Pediatr Endocrinol Metab. 2016;29(4):395-400.

Devaraj S, Jian I, Yun JM, Bremer. A demonstration of increased toll-like receptor 2 and toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complications. Metabolism. 2011;60(2):256-9.

Kaur H, Donaghue KC, Chan AK, Benitez-Aguirre P, Hing S, Lloyd M, et al. Vitamin D deficiency is associated with retinopathy in children and adolescents with type 1 diabetes. Diabetes Care. 2011;34(6):1400-2.

Joergensen C, Hovind P, Schmedes A, Parving HH, Rossing P. Vitamin D levels, microvascular complications, and mortality in type 1 diabetes. Diabetes Care. 2011;34(5):1081-5.

Boer IH, Sachs MC, Cleary PA, Hoofnagle AN, Lachin JM, Molitch ME, et al. Diabetes control and complication trial/epidemiology of diabetes interventions and complications study research group: circulating vitamin d metabolites and kidney disease in type 1 diabetes. J Clin Endocrinol Metab. 2012;97(12):4780-8.

Shimo N, Yasuda T, Kaneto H, Katakami N, Kuroda A, Sakamoto F, et al. Vitamin D deficiency is significantly associated with retinopathy in young Japanese type 1 diabetic patients. Diabetes Res Clin Pract. 2014;106(2):e 41-3.

Alam U, Arul-Devah V, Javed S, Malik RA. vitamin d and diabetic complications: true or false prophet? Diabetes Ther. 2016;7(1):11-26.

Nwosu BU, Maranda L. The effects of vitamin D supplementation on hepatic dysfunction, vitamin D status, and glycemic control in children and adolescents with vitamin D deficiency and either type 1 or type 2 diabetes mellitus. PLoS One. 2014;9(6):e 99646.

World Health Organization. Obesity: preventing and managing the global epidemic. Report of a World Health Organization Consultation. Geneva: WHO; 2000. (WHO Obesity Technical Report Series, n. 284).

Cadenhead K. Council on health promotion: the vitamin D debate. BC Med J. 2015;57(9):414.

Muscogiuri G, Mitri J, Mathieu C, Badenhoop K, Tamer G, Orio F, et al. Mechanisms in endocrinology: vitamin D as a potential contributor in endocrine health and disease; Eur J Endocrinol. 2014;171(3):R101-10.

Mäkinen MV, Mykkänen J, Ilonen J, Veijola R, Hyöty H, Knip M, et al. An increase in serum 25-hydroxyvitamin d concentrations preceded a plateau in type 1 diabetes incidence in finnish children. J Clin Endocrinol Metab. 2014;99(11):e2353-6.

Svoren BM, Volkening LK, Wood JR, Laffel LM. Significant vitamin D deficiency in youth with type 1 diabetes mellitus. J Pediatr. 2009;154(1):132-4.

Savastio S, Cadario F, Genoni G, Bellomo G, Bagnati M, Secco G, et al. Vitamin D Deficiency and Glycemic Status in Children and Adolescents with Type 1 Diabetes Mellitus. PLoS One. 2016;11(9):e0162554.

Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Yakout SM, Aljohani NJ, et al. Lower vitamin D status is more common among Saudi adults with diabetes mellitus type 1 than in non-diabetics. BMC Public Health. 2014;14:153.

Daga RA, Laway BA, Shah ZA, Mir SA, Kotwal SK, Zargar AH. High prevalence of vitamin D deficiency among newly diagnosed youth-onset diabetes mellitus in north India. Arq Bras Endocrinol Metab. 2012;56(7):423-8.

Zipitis CS, Akobeng AK. Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child. 2008;93(6):512-7.

Raab,J, Giannopoulou EZ, Schneider S, Warncke K, Krasmann M, Winkler C, et al. Prevalence of vitamin D deficiency in pre-type 1 diabetes and its association with disease progression. Diabetologia. 2014;57(5):902-8.

Miettinen ME, Reinert L, Kinnunen L, Harjutsalo V, Koskela P, Surcel HM, et al. Serum 25-hydroxyvitamin D level during early pregnancy and type 1 diabetes risk in the offspring. Diabetologia. 2012;55(5):1291-4.

Al Sawah S, Compher CW, Hanlon AL, Lipman TH. 25-Hydroxyvitamin D and glycemic control: a cross-sectional study of children and adolescents with type 1 diabetes. Diabetes Res Clin Pract. 2016;115:54-9.

Vitamin D supplement in early childhood and risk for type I (insulin-dependent) diabetes mellitus. The EURODIAB Substudy 2 Study Group. Diabetologia. 1999;42(1):51-4.

Treiber G, Prietl B, Fröhlich-Reiterer E, Lechner E, Ribitsch A, Fritsch M, et al. Cholecalciferol supplementation improves suppressive capacity of regulatory T-cells in young patients with new-onset type 1 diabetes mellitus: a randomized clinical trial. Clin Immunol. 2015;161(2):217-24.

Hossein-nezhad A, Holick MF. Vitamin D for health: a global perspective. Mayo Clinic Proc. 2013;88(7):720-55.

Published

2018-06-21

How to Cite

Ferraz, C. L. H., Mendes, A. D. N., Ferraz, T. M. B. L., & Silva, C. A. B. da. (2018). Association between vitamin D, glycemic control and microvascular complications in type 1 diabetes. Brazilian Journal in Health Promotion, 31(2). https://doi.org/10.5020/18061230.2018.6993

Issue

Section

Original Articles